Back to top

NBIX Maintained by Morgan Stanley -- Price Target Raised to $196

NBIX Maintained by Morgan Stanley -- Price Target Raised to $196

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Neurocrine Biosciences, Inc. (NBIX)